BPC-157 + TB-500: the stack guide
BPC-157 and TB-500 are the most-discussed soft-tissue recovery pair. They act on different repair pathways, so they are often run together for tendon, ligament, and muscle injuries that have plateaued on either compound alone.
Why BPC-157 and TB-500 pair well
BPC-157 promotes local angiogenesis and accelerates fibroblast and tenocyte migration at the injury site. TB-500 (a synthetic fragment of Thymosin Beta-4) upregulates actin polymerization and recruits stem cells systemically. Together they pair a fast local healing response with a broader systemic one.
Suggested cadence
A widely reported pattern is BPC-157 250–500 mcg subcutaneous once or twice daily, paired with TB-500 2.0–2.5 mg twice weekly for 4–6 weeks. Many users taper TB-500 to a single weekly maintenance dose after the loading phase.
This is informational only — dosing should always be individualized and discussed with a qualified clinician.
Reconstitution notes
BPC-157: A common ratio is 2 ml of bacteriostatic water for a 5 mg vial. Open the BPC-157 calculator →
TB-500: A common ratio is 3 ml of bacteriostatic water for a 10 mg vial. Open the TB-500 calculator →
Side effects to watch for
Both compounds are well tolerated in user reports, but injection-site irritation, transient fatigue, and lightheadedness are the most common complaints when stacking. Start each compound separately for a few days before combining so any reaction can be attributed.
The two compounds
Track this stack on iPhone
Peptide Protocol schedules both compounds, calculates reconstitution, and rotates injection sites automatically.
See the app →Frequently asked questions
Why stack BPC-157 with TB-500?
BPC-157 and TB-500 are the most-discussed soft-tissue recovery pair. They act on different repair pathways, so they are often run together for tendon, ligament, and muscle injuries that have plateaued on either compound alone.
What is the typical BPC-157 + TB-500 dose?
A widely reported pattern is BPC-157 250–500 mcg subcutaneous once or twice daily, paired with TB-500 2.0–2.5 mg twice weekly for 4–6 weeks. Many users taper TB-500 to a single weekly maintenance dose after the loading phase.
Can you inject BPC-157 and TB-500 in the same syringe?
Many users co-administer GHRH + GHRP pairs (like CJC-1295 + Ipamorelin) in a single syringe to reduce injections, since both are stable in bacteriostatic water for short periods. For other pairs, draw and inject separately to minimize compatibility risk and to attribute any reaction to the correct compound.
What side effects should I watch for?
Both compounds are well tolerated in user reports, but injection-site irritation, transient fatigue, and lightheadedness are the most common complaints when stacking. Start each compound separately for a few days before combining so any reaction can be attributed.
How long should a BPC-157 + TB-500 cycle run?
Most user-reported cycles run 4–12 weeks depending on the goal. GH-axis stacks are typically cycled with a break of 4 weeks or more between blocks to preserve receptor sensitivity. Soft-tissue stacks are usually run continuously until the injury resolves.
Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.